Complimentary Digital Strategy for Pharma & MedTech

Enhancing Core Product Value Through Strategically Designed Digital Complements

For pharmaceutical and MedTech organizations, digital capabilities can be a powerful value multiplier. Yet many digital “wraparounds” fail to gain traction in the market because they are loosely connected to the core product, insufficiently integrated into clinical workflows, or misaligned with commercial realities. Success requires digital complements that solve meaningful problems for providers, payers and patients - and reinforce, rather than distract from, the primary therapy or device.

The Challenge

Life sciences organizations increasingly recognize the potential of digital tools to improve adherence, outcomes, and differentiation. However, without a clear strategic role, digital initiatives often become underutilized assets. The challenge is not whether to invest in digital - but where, how, and to what commercial end.

Engagement Pillars

Engagements typically focus on:

Digital Asset Integration: Determining where digital capabilities can most effectively reduce barriers to therapy or device adoption and use.

SaMD & Connected Ecosystems: Assessing the regulatory, clinical, and commercial viability of Software as a Medical Device (SaMD) and connected health extensions.

Commercial Pathways: Aligning digital tools with existing sales, marketing, and medical affairs workflows to support adoption at scale.

Evidence Generation: Identifying opportunities for digital tools to generate real-world data and evidence that strengthen the product’s value proposition.

Who This Is For

This engagement is designed for:

• Pharma and MedTech leaders responsible for digital solutions, product strategy, lifecycle management, or differentiation

• Teams evaluating whether and how digital can support launch, growth, or post-launch optimization

• Organizations seeking clarity before investing in digital development, partnerships, or acquisitions

How the Engagement Works

This assessment follows Bearing On Health’s proven four-phase approach:

• Opportunity Framing – Clarifying strategic objectives and target markets

• Customer Discovery – Internal and external interviews to understand real demand and decision drivers

• Market & Competitive Analysis – Assessing positioning against relevant alternatives

• Strategic Recommendations – Delivering an executive-ready roadmap for action

The Adam Kaufman Advantage

Every engagement is led personally by Adam Kaufman, PhD, bringing decades of experience as an operator and advisor across digital health, MedTech, and life sciences. The work is grounded in commercial realities and designed to be execution-ready—not conceptual or exploratory for its own sake.